Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Int J Pharm Pract. 2022 May 26;30(2):136-142. doi: 10.1093/ijpp/riab085.
During the ongoing coronavirus 2019 (COVID-19) pandemic, chronic disease management and medication adherence have become challenging; thus, health-related quality of life may have been compromised. As highly trusted healthcare providers, pharmacies in Saudi Arabia have undergone restructuring or redesign to cope with the current demands during the pandemic. The study assessed satisfaction levels of patients with chronic diseases concerning pharmaceutical care services provided during COVID-19 in addition to medication adherence and quality of life during the pandemic.
An online questionnaire-based cross-sectional study was administered. Saudi residents suffering from chronic diseases and receiving pharmaceutical care from a hospital or community pharmacy during the COVID-19 pandemic were eligible. The survey was created using Google Forms and distributed through online channels. The survey targeted 385 participants.
A sample of 317 patients was included. More than half had missed a follow-up visit for their chronic conditions since the beginning of the pandemic. The overall mean score ± standard deviation for the satisfaction level with pharmaceutical care services was 22.0 ± 10.3 on a scale of 0-36 with different satisfaction levels for different services. In addition to a good level of medication adherence, a high percentage of these patients reported no problem in most of the dimensions of the EQ-5D scale.
Pharmacists should take a more proactive and consultive role to deliver healthcare needs of patients with a chronic condition and be aware of patient expectations from a pharmacist in situations, such as the current pandemic.
在当前 2019 年冠状病毒病（COVID-19）大流行期间，慢性病管理和药物依从性变得具有挑战性；因此，健康相关的生活质量可能受到影响。作为深受信赖的医疗保健提供者，沙特阿拉伯的药店已经进行了重组或重新设计，以应对大流行期间的当前需求。本研究评估了慢性病患者对 COVID-19 期间提供的药物治疗服务的满意度，以及大流行期间的药物依从性和生活质量。
进行了一项基于在线问卷的横断面研究。符合条件的是在 COVID-19 大流行期间正在从医院或社区药房接受药物治疗的患有慢性病的沙特居民。该调查使用 Google 表单创建，并通过在线渠道分发。该调查针对 385 名参与者。
纳入了 317 名患者的样本。自大流行开始以来，超过一半的患者错过了慢性病的随访就诊。药物治疗服务满意度的总体平均得分±标准偏差为 22.0±10.3，评分范围为 0-36，不同服务的满意度不同。除了具有良好的药物依从性外，这些患者中有很大一部分报告在 EQ-5D 量表的大多数维度上没有问题。
药剂师应发挥更积极主动和咨询的作用，满足慢性病患者的医疗需求，并了解在当前大流行等情况下患者对药剂师的期望。
